<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8098028</article-id>
    <article-id pub-id-type="pmid">32871004</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btaa762</article-id>
    <article-id pub-id-type="publisher-id">btaa762</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Databases and Ontologies</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CaNDis: a web server for investigation of causal relationships between diseases, drugs and drug targets</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Škrlj</surname>
          <given-names>Blaž</given-names>
        </name>
        <aff><institution>Department of Knowledge Technologies, Jožef Stefan Institute</institution>, <country country="SI">Slovenia</country></aff>
        <aff><institution>Jožef Stefan International Postgraduate School</institution>, <country country="SI">Slovenia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Eržen</surname>
          <given-names>Nika</given-names>
        </name>
        <aff><institution>Department of Knowledge Technologies, Jožef Stefan Institute</institution>, <country country="SI">Slovenia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lavrač</surname>
          <given-names>Nada</given-names>
        </name>
        <aff><institution>Department of Knowledge Technologies, Jožef Stefan Institute</institution>, <country country="SI">Slovenia</country></aff>
        <aff><institution>Jožef Stefan International Postgraduate School</institution>, <country country="SI">Slovenia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0465-1762</contrib-id>
        <name>
          <surname>Kunej</surname>
          <given-names>Tanja</given-names>
        </name>
        <aff><institution>Department of Animal Science, Biotechnical Faculty, University of Ljubljana</institution>, <country country="SI">Slovenia</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0160-3375</contrib-id>
        <name>
          <surname>Konc</surname>
          <given-names>Janez</given-names>
        </name>
        <xref rid="btaa762-cor1" ref-type="corresp"/>
        <aff><institution>Theory Department, National Institute of Chemistry</institution>, SI-1000 Ljubljana, <country country="SI">Slovenia</country></aff>
        <!--konc@cmm.ki.si-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Cowen</surname>
          <given-names>Lenore</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btaa762-cor1">To whom correspondence should be addressed. <email>konc@cmm.ki.si</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>3</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-09-01">
      <day>01</day>
      <month>9</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>9</month>
      <year>2020</year>
    </pub-date>
    <volume>37</volume>
    <issue>6</issue>
    <fpage>885</fpage>
    <lpage>887</lpage>
    <history>
      <date date-type="received">
        <day>10</day>
        <month>2</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>7</month>
        <year>2020</year>
      </date>
      <date date-type="editorial-decision">
        <day>23</day>
        <month>8</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>25</day>
        <month>8</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits 
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btaa762.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Causal biological interaction networks represent cellular regulatory pathways. Their fusion with other biological data enables insights into disease mechanisms and novel opportunities for drug discovery.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We developed Causal Network of Diseases (CaNDis), a web server for the exploration of a human causal interaction network, which we expanded with data on diseases and FDA-approved drugs, on the basis of which we constructed a disease–disease network in which the links represent the similarity between diseases. We show how CaNDis can be used to identify candidate genes with known and novel roles in disease co-occurrence and drug–drug interactions.</p>
      </sec>
      <sec id="s3">
        <title>Availabilityand implementation</title>
        <p>CaNDis is freely available to academic users at <ext-link xlink:href="http://candis.ijs.si" ext-link-type="uri">http://candis.ijs.si</ext-link> and <ext-link xlink:href="http://candis.insilab.org" ext-link-type="uri">http://candis.insilab.org</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Slovenian Research Agency</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004329</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>P2-0103</award-id>
        <award-id>N2-0078</award-id>
        <award-id>N1-0142</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Protein–protein and protein–drug interaction networks are becoming increasingly important for drug development (<xref rid="btaa762-B1" ref-type="bibr">Ashburn <italic toggle="yes">et al.</italic>, 2004</xref>). Such biological interactions, whether predicted or experimental, are stored in various databases (<xref rid="btaa762-B11" ref-type="bibr">Konc <italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btaa762-B16" ref-type="bibr">Szklarczyk <italic toggle="yes">et al.</italic>, 2019</xref>). However, the causal relationships between the interaction partners remain relatively unexplored. A causal relationship occurs when e.g. a transcription factor increases the expression of a particular protein. Knowledge of these relationships could open up new avenues for drug development and improve our understanding of the disease processes.</p>
    <p>Tools to explore networks of causal relationships are available (<xref rid="btaa762-B3" ref-type="bibr">Boué <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btaa762-B13" ref-type="bibr">Licata <italic toggle="yes">et al.</italic>, 2020</xref>); however, the fusion of these networks with the knowledge about diseases and drugs into heterogeneous causal networks, should enable even higher understanding of diseases as well as more efficient drug discovery. In particular, such networks could be used for the study of disease co-occurrence, the simultaneous presence of two or more diseases in a patient (<xref rid="btaa762-B9" ref-type="bibr">Hu <italic toggle="yes">et al.</italic>, 2016</xref>).</p>
    <p>We developed Causal Network of Diseases (CaNDis), a web server that enables visual exploration of a causal network of protein–protein interactions enriched with annotations on diseases and drugs. We also constructed a new disease–disease network. Here, each node is a subnetwork in the original causal network, in which all the nodes are linked to the same disease. A score is assigned to a link between a pair of diseases based on the connectivity of the two subnetworks, representing disease similarity. CaNDis is an intuitive web server based on a fast WebGL viewer (see sections ‘Software aspects and scaling’ and ‘Comparison with other tools’ in <xref rid="sup1" ref-type="supplementary-material">Supplementary Information</xref>). It facilitates drug discovery with respect to the identification of disease co-occurrence and drug–drug interactions at the level of drugs, genes, proteins and diseases.</p>
  </sec>
  <sec>
    <title>2 The CaNDis web server</title>
    <p>The CaNDis heterogeneous causal network is based on the CBN (<xref rid="btaa762-B3" ref-type="bibr">Boué <italic toggle="yes">et al.</italic>, 2015</xref>) and SIGNOR 2.0 (<xref rid="btaa762-B13" ref-type="bibr">Licata <italic toggle="yes">et al.</italic>, 2020</xref>) causal biological networks. It is extended with protein–RNA interactions from the PRD database (<xref rid="btaa762-B7" ref-type="bibr">Fujimori <italic toggle="yes">et al.</italic>, 2012</xref>) and drug–gene interactions from the DGIdb database (<xref rid="btaa762-B5" ref-type="bibr">Cotto <italic toggle="yes">et al.</italic>, 2018</xref>); gene nodes are superimposed with the gene–disease annotations from the DisGeNET database (<xref rid="btaa762-B14" ref-type="bibr">Piñero <italic toggle="yes">et al.</italic>, 2020</xref>). Causal pathways are merged into a single network containing the interacting proteins as nodes and the causal relationships, such as increase or decrease in expression levels, as links (see section ‘The CaNDis network’ in <xref rid="sup1" ref-type="supplementary-material">Supplementary Information</xref>).</p>
    <p>Gene–disease annotations are added as attributes to the protein nodes and drugs and RNA are added as new nodes, which are linked to their respective target protein nodes. The obtained heterogeneous causal network contains annotations on more than 3000 complex diseases as well as on the FDA approved drugs to enable the investigation of diseases (i.e. co-occurrence of diseases) and drug–drug interactions (see section ‘Use in drug–drug interactions’ in <xref rid="sup1" ref-type="supplementary-material">Supplementary Information</xref>).</p>
    <p>A new disease–disease network is also developed from the heterogeneous causal network (sections ‘Disease–disease network construction’ and ‘Normalized disease–disease similarity score’ in <xref rid="sup1" ref-type="supplementary-material">Supplementary Information</xref>), and is available on the web server.</p>
  </sec>
  <sec>
    <title>3 Use for identification of genes with roles in disease co-occurrence</title>
    <p>According to epidemiological studies, patients with central nervous system (CNS) disorders, that is, Alzheimer’s disease, Parkinson’s disease and schizophrenia, are less likely to develop certain cancers (colorectal, lung and prostate), and vice versa. This inverse co-occurrence is attributed to a set of proteins, including the proteins coded by the <italic toggle="yes">TP53</italic> and <italic toggle="yes">BCL2</italic> genes (<xref rid="btaa762-B2" ref-type="bibr">Behrens <italic toggle="yes">et al.</italic>, 2009</xref>; <xref rid="btaa762-B10" ref-type="bibr">Ibáñez <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btaa762-B17" ref-type="bibr">Tabarés-Seisdedos <italic toggle="yes">et al.</italic>, 2009</xref>), both of which are down-regulated in cancers and up-regulated in CNS disorders. Using ‘colorectal carcinoma’ and ‘schizophrenia’ as the inputs to the CaNDis web server, we successfully identified the <italic toggle="yes">TP53</italic> tumor suppressor gene and the <italic toggle="yes">BCL2</italic> anti-apoptotic gene as those in common to both the diseases (<italic toggle="yes">BCL2</italic> network is shown in<xref rid="btaa762-F1" ref-type="fig">Fig. 1</xref>). In addition, we also found proteins that have not yet been associated with either disease (<xref rid="btaa762-B14" ref-type="bibr">Piñero <italic toggle="yes">et al.</italic>, 2020</xref>), but which could play a role in this inverse disease co-occurrence due to their interactions with the protein coded by the <italic toggle="yes">BCL2</italic> gene (the list of proteins is in the caption of <xref rid="btaa762-F1" ref-type="fig">Fig. 1</xref>). Literature search showed that some of the identified proteins are indeed associated with both diseases. For example, the oncoprotein coded by the <italic toggle="yes">DDIT3</italic> gene (<xref rid="btaa762-B6" ref-type="bibr">Engström <italic toggle="yes">et al.</italic>, 2006</xref>) is associated with lung cancer (<xref rid="btaa762-B12" ref-type="bibr">Li <italic toggle="yes">et al.</italic>, 2015</xref>) and upregulated in schizophrenia (<xref rid="btaa762-B18" ref-type="bibr">Umeda-Yano <italic toggle="yes">et al.</italic>, 2013</xref>). Similarly, <italic toggle="yes">MAPK8</italic> plays a role in both colorectal cancer and schizophrenia (<xref rid="btaa762-B4" ref-type="bibr">Chandrasekaran <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btaa762-B8" ref-type="bibr">He <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btaa762-B15" ref-type="bibr">Szatkiewicz <italic toggle="yes">et al.</italic>, 2014</xref>). This illustrates the use of the CaNDis web server's innovative network visualization to quickly suggest candidate proteins with potential new roles in co-occurrence of diseases.
</p>
    <fig position="float" id="btaa762-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>CaNDis web server causal interaction network for the <italic toggle="yes">BCL2</italic> gene. Left: proteins (identified by their gene names) associated with schizophrenia (yellow circles), cancer (purple circle), both diseases (blue circles) or none of the diseases (grey circles) represented as a 3D interaction network. Drugs are black triangles. Highlighted are the <italic toggle="yes">BCL2</italic> gene in the middle and its neighbors. Right: tabular view of the same interactions labeled with causal relationships (e.g. decreases). Some of the relevant neighbors of <italic toggle="yes">BCL2</italic> gene are <italic toggle="yes">DDIT3, MAPK8, MAPK14, MAPK1, CREB1, PRKCA, CASP3</italic> and <italic toggle="yes">BECN1</italic> (all genes are available on the web server)</p>
      </caption>
      <graphic xlink:href="btaa762f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the Slovenian Research Agency [P2-0103, N2-0078 and N1-0142]. The first author (B.Š.) acknowledges support under the junior researcher programme.</p>
    <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btaa762_Supplementary_Data</label>
      <media xlink:href="btaa762_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btaa762-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ashburn</surname>
 <given-names>T.T.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2004</year>) 
<article-title>Drug repositioning: identifying and developing new uses for existing drugs</article-title>. <source>Nat. Rev. Drug Discov</source>., <volume>3</volume>, <fpage>673</fpage>–<lpage>683</lpage>.<pub-id pub-id-type="pmid">15286734</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Behrens</surname>
 <given-names>M.I.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2009</year>) 
<article-title>A common biological mechanism in cancer and Alzheimer’s disease?</article-title><source>Curr. Alzheimer Res</source>., <volume>6</volume>, <fpage>196</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">19519301</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boué</surname>
 <given-names>S.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2015</year>) 
<article-title>Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems</article-title>. <source>Database (Oxford)</source>, <volume>2015</volume>, bav030.</mixed-citation>
    </ref>
    <ref id="btaa762-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chandrasekaran</surname>
 <given-names>S.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2012</year>) 
<article-title>A network view on Schizophrenia related genes</article-title>. <source>Network Biol</source>., <volume>2</volume>, <fpage>16</fpage>–<lpage>25</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa762-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cotto</surname>
 <given-names>K.C.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2018</year>) 
<article-title>DGIdb 3.0: a redesign and expansion of the drug–gene interaction database</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>D1068</fpage>–<lpage>D1073</lpage>.<pub-id pub-id-type="pmid">29156001</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Engström</surname>
 <given-names>K.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2006</year>) 
<article-title>The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells</article-title>. <source>Am. J. Pathol</source>., <volume>168</volume>, <fpage>1642</fpage>–<lpage>1653</lpage>.<pub-id pub-id-type="pmid">16651630</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fujimori</surname>
 <given-names>S.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2012</year>) 
<article-title>PRD: a protein–RNA interaction database</article-title>. <source>Bioinformation</source>, <volume>8</volume>, <fpage>729</fpage>–<lpage>730</lpage>.<pub-id pub-id-type="pmid">23055619</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname>
 <given-names>W.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2012</year>) 
<article-title>Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation</article-title>. <source>Autophagy</source>, <volume>8</volume>, <fpage>1811</fpage>–<lpage>1821</lpage>.<pub-id pub-id-type="pmid">23051914</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname>
 <given-names>J.X.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2016</year>) 
<article-title>Network biology concepts in complex disease comorbidities</article-title>. <source>Nat. Rev. Genet</source>., <volume>17</volume>, <fpage>615</fpage>–<lpage>629</lpage>.<pub-id pub-id-type="pmid">27498692</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ibáñez</surname>
 <given-names>K.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2014</year>) 
<article-title>Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses</article-title>. <source>PLoS Genet</source>., <volume>10</volume>, <fpage>e1004173</fpage>.<pub-id pub-id-type="pmid">24586201</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konc</surname>
 <given-names>J.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2017</year>) 
<article-title>GenProBiS: web server for mapping of sequence variants to protein binding sites</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>W253</fpage>–<lpage>W259</lpage>.<pub-id pub-id-type="pmid">28498966</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
 <given-names>T.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2015</year>) 
<article-title>DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells</article-title>. <source>J. Biol. Chem</source>., <volume>290</volume>, <fpage>11108</fpage>–<lpage>11118</lpage>.<pub-id pub-id-type="pmid">25770212</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Licata</surname>
 <given-names>L.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2020</year>) 
<article-title>SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D504</fpage>–<lpage>D510</lpage>.<pub-id pub-id-type="pmid">31665520</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piñero</surname>
 <given-names>J.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2020</year>) 
<article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D845</fpage>–<lpage>D855</lpage>.<pub-id pub-id-type="pmid">31680165</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Szatkiewicz</surname>
 <given-names>J.P.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2014</year>) 
<article-title>Copy number variation in schizophrenia in Sweden</article-title>. <source>Mol. Psychiatry</source>, <volume>19</volume>, <fpage>762</fpage>–<lpage>773</lpage>.<pub-id pub-id-type="pmid">24776740</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Szklarczyk</surname>
 <given-names>D.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2019</year>) 
<article-title>STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D607</fpage>–<lpage>D613</lpage>.<pub-id pub-id-type="pmid">30476243</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tabarés-Seisdedos</surname>
 <given-names>R.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2009</year>) 
<article-title>Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer</article-title>. <source>Mol. Psychiatry</source>, <volume>14</volume>, <fpage>563</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">19204725</pub-id></mixed-citation>
    </ref>
    <ref id="btaa762-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Umeda-Yano</surname>
 <given-names>S.</given-names></string-name></person-group>
 <etal>et al</etal> (<year>2013</year>) 
<article-title>The regulation of gene expression involved in TGF-β signaling by ZNF804A, a risk gene for schizophrenia</article-title>. <source>Schizophr. Res</source>., <volume>146</volume>, <fpage>273</fpage>–<lpage>278</lpage>.<pub-id pub-id-type="pmid">23434502</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
